Chronicle Journal: Finance

'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief says

FDA Commissioner Scott Gottlieb said the U.S. has a "wacky" system where discounts on drug prices don't flow to patients paying for drugs. Rebates are a favorite target of pharmaceutical companies, who say pharmaceutical benefit managers extract huge discounts but keep them for themselves instead of sharing the savings with patients.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.